Concepedia

Publication | Open Access

Pembrolizumab for patients with PD-L1–positive advanced carcinoid or pancreatic neuroendocrine tumors: Results from the KEYNOTE-028 study

57

Citations

0

References

2017

Year

No additional data available for this publication yet. Check back later!